BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501 [PMID: 38591087 DOI: 10.4239/wjd.v15.i3.488]
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm
Number Citing Articles
1
Shan Gao. Crosstalk between microRNAs and autophagy in adipocyte differentiation: emerging therapeutic targets for obesity. Adipocyte 2025; 14(1) doi: 10.1080/21623945.2025.2580741
2
You Wang, Yuan Wang, Pei Pi, Dan Luo, Min Ning, Gang Ye. MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95952-5
3
Xiaoyu Wang, Linlin Li, Bowen Tian, Hongdong Li, Xiaodong Zhu, Shumei Shi. MiR-509-3p Targets YAP1 to Regulate Inflammatory Cytokines Against Hyperglycemia-Induced Renal Tubular Cell Damage in Diabetic Kidney Disease. Combinatorial Chemistry & High Throughput Screening 2026; 29(14) doi: 10.2174/0113862073446094251111052119
4
Javier Donate-Correa, Ainhoa González-Luis, Jésica Díaz-Vera, Juan Ramón Hernandez-Fernaud. MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(7): 1398-1403 doi: 10.4239/wjd.v15.i7.1398
5
Jiamian Geng, Sijia Ma, Hui Tang, Chun Zhang. Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update. Biomedicines 2025; 13(6) doi: 10.3390/biomedicines13061424
6
Ashraf Al Madhoun. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(9): 1837-1841 doi: 10.4239/wjd.v15.i9.1837
7
Hirofumi Sakuma, Satoshi Kawaguchi, Yuya Kobayashi, Akiko Koizumi, Naoki Nakagawa. MicroRNA Regulation in Kidney Interstitial Fibrosis. Epigenomes 2026; 10(1) doi: 10.3390/epigenomes10010021